
ReCaP
@impact_recap
National audit assessing the management of rectal cancer during the COVID-19 pandemic. ACPGBI endorsed sub-study of @IMPACTaudit
ID: 1255888193918033923
30-04-2020 15:54:20
84 Tweet
454 Followers
413 Following




Practice-changing trial FOLFIRINOX▶️Chemoradiotherapy▶️TME▶️AdjuvantChemotherapy now appears the gold standard for T3/4 rectal cancer. Better disease-free 3 yr survival #tailoringTNT @ACPGBI European Society of Coloproctology PelvEx European Society of Surgical Oncology (ESSO) UKPEN IMPACT Audit ReCaP

Delighted to share the results of the first 500 patients entered into our database! A snapshot of how rectal cancer management changed post lockdown A massive Thankyou to all of our collaborators for their ongoing work! @ACPGBI The Royal College of Surgeons of England #collaboration academic.oup.com/bjs/advance-ar…

ReCaP Michael K Lim MD FRCS @ACPGBI The Royal College of Surgeons of England Much more to come from this important piece of work as we follow the cohort over the next few years. Thank you also to our funders Bowel Research UK and also IMPACT Audit for supporting and facilitating the rapid rollout of this study



Development of robotic curricula for #colorectalsurgery is essential. Marcos Gomez Ruiz highlights the Colorobotica programme @rocs2021 European Society of Coloproctology #ROCS2021 🤖Standardised stepwise program 🤖Prerequisite criteria 🤖Regular objective assessment 🤖High volume & access is 🔑



Delighted to share early data on behalf of the team! More results to come! Dale Vimalachandran Deena Harji ReCaP Bowel Research UK #collaborativeresearch


Great time in London at The Royal College of Surgeons of England for the National Institute for Health and Care Research Clinical Research Network meeting. Exciting surgical trials coming from this research collaborative RESOLVE Study ReCaP @SF-CORNER. Thanks for the support & vision from Dale Vimalachandran & susan moug! #colorectalresearch



